Characteristics and outcomes of type 2 diabetes (T2DM) patients treated with canagliflozin (CANA) in a specialty diabetes clinic.
Phase of Trial: Phase IV
Latest Information Update: 10 Oct 2017
At a glance
- Drugs Canagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 10 Oct 2017 New trial record